Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
APVO

Aptevo Therapeutics

$4.49

-0.03 (-0.66%)

05:33
08/10/18
08/10
05:33
08/10/18
05:33
Recommendations
Aptevo Therapeutics analyst commentary at Piper Jaffray »

Aptevo Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
APVO

Aptevo Therapeutics

$4.87

-0.11 (-2.21%)

04:55
06/20/18
06/20
04:55
06/20/18
04:55
Conference/Events
Aptevo Therapeutics management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

APVO

Aptevo Therapeutics

$4.98

0.04 (0.81%)

04:55
06/19/18
06/19
04:55
06/19/18
04:55
Conference/Events
Aptevo Therapeutics management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

APVO

Aptevo Therapeutics

$5.05

-0.18 (-3.44%)

07:44
06/15/18
06/15
07:44
06/15/18
07:44
Conference/Events
Aptevo Therapeutics management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

APVO

Aptevo Therapeutics

$5.41

-0.05 (-0.92%)

09:06
05/29/18
05/29
09:06
05/29/18
09:06
Hot Stocks
Aptevo Therapeutics announces preclinical data on APVO210 activity »

Aptevo Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APVO

Aptevo Therapeutics

$5.66

-0.17 (-2.92%)

11:24
05/16/18
05/16
11:24
05/16/18
11:24
Conference/Events
Aptevo Therapeutics management to meet with Roth Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

APVO

Aptevo Therapeutics

$5.03

0.68 (15.63%)

13:51
05/10/18
05/10
13:51
05/10/18
13:51
Recommendations
Aptevo Therapeutics analyst commentary at Piper Jaffray »

Aptevo Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APVO

Aptevo Therapeutics

$4.20

-0.13 (-3.00%)

04:55
04/24/18
04/24
04:55
04/24/18
04:55
Conference/Events
Aptevo Therapeutics management to meet with Piper Jaffray »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

APVO

Aptevo Therapeutics

$4.33

0.01 (0.23%)

04:55
04/23/18
04/23
04:55
04/23/18
04:55
Conference/Events
Aptevo Therapeutics management to meet with Piper Jaffray »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

APVO

Aptevo Therapeutics

$4.25

-0.07 (-1.62%)

10:14
04/20/18
04/20
10:14
04/20/18
10:14
Conference/Events
Aptevo Therapeutics management to meet with Piper Jaffray »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.